Description—- Tirzepatide
Tirzepatide and Semaglutide have a similar sequence. The Lys side chain in the sequence is modified with PEG, which is a functional group of the polypeptide and can increase the water solubility of the sequence. The main physiological function of Tirzepatide is a dual agonist of glucose-dependent insulin nutritional polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor. It is being developed for the treatment of type 2 diabetes and has entered the clinical stage.
Specifications—- Tirzepatide
| English Name: Tirzepatide, GIP\GLP-1 | |
| Sequence: Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
|
| CAS: 2023788-19-2 |
Assay:98%+ |
| Molecular weight: 4813.45g/mol | Molecular formula: C225H348N48O68 |
| Appearance: White powder | Remarks: Only for research, not for human |
| Packing specifications (powder): 100mg, 1g, 10g, 100g,1kg or at customers request | Storage conditions: 2~8 °C |
Our Advantages—- Tirzepatide
Professional peptide supplier
High purity custom peptide
Competitive price
